The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
Brief Report
PreviousPrevious
Volume 336:839-845 March 20, 1997 Number 12
NextNext

Immunologic Analysis of a Spinal Cord–Biopsy Specimen from a Patient with Human T-Cell Lymphotropic Virus Type I–Associated Neurologic Disease
Michael C. Levin, M.D., Tanya J. Lehky, M.D., Alfred N. Flerlage, B.S., David Katz, M.D., Douglas W. Kingma, M.D., Elaine S. Jaffe, M.D., John D. Heiss, M.D., Nicholas Patronas, M.D., Henry F. McFarland, M.D., and Steven Jacobson, Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Human T-cell lymphotropic virus type I (HTLV-I) is associated with adult T-cell leukemia and a chronic progressive neurologic disease, HTLV-I–associated myelopathy–tropical spastic paraparesis (hereafter referred to as HTLV-I–associated myelopathy).1,2,3,4,5 HTVL-I is endemic in Japan, the Caribbean, Africa, and South America.5 Risk factors for infection include sexual contact, exchange of blood products, and vertical transmission from mother to child.5 HTLV-I–associated myelopathy causes progressive myelopathy with atrophy of the spinal cord.5,6 Subcortical white-matter lesions are sometimes present on magnetic resonance imaging.5,6,7 Cerebrospinal fluid shows pleocytosis, elevated titers of IgG, and oligoclonal bands.8,9,10 Autopsy results correlate with neurologic findings and show spinal cord . . . [Full Text of this Article]

Case Report

Methods

Immunocytochemical Analysis

PCR

Cell Culture

Cytotoxic T-Lymphocyte Assays

Flow Cytometry

Results

Discussion


Source Information

From the Viral Immunology Section, Neuroimmunology Branch, National Institutes of Health (M.C.L., T.J.L., A.N.F., H.F.M., S.J.); the Neurosurgery Branch (J.D.H.) and the Office of the Clinical Director (D.K.), National Institute of Neurological Diseases and Stroke; and the Departments of Hematopathology (D.W.K., E.S.J.) and Neuroradiology (N.P.), National Cancer Institute — all in Bethesda, Md.

Address reprint requests to Dr. Jacobson at the Neuroimmunology Branch, NIH/NINDS, 10 Center Dr., Bldg. 10, Rm. 5B-16, Bethesda, MD 20892.

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.